Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 1467657)

Published in J Anat on July 01, 1997

Authors

S Bord1, A Horner, R M Hembry, J J Reynolds, J E Compston

Author Affiliations

1: Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, London, UK.

Articles cited by this

Matrix metalloproteinases: a review. Crit Rev Oral Biol Med (1993) 9.03

Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J (1986) 3.31

Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J (1987) 2.54

Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone. J Bone Miner Res (1995) 2.01

Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. Biochem J (1989) 1.89

The role of the C-terminal domain in collagenase and stromelysin specificity. J Biol Chem (1992) 1.85

Normal osteoid tissue. J Clin Pathol (1972) 1.79

Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum. J Cell Sci (1985) 1.73

Fluctuation of mineral apposition rate at individual bone-remodeling sites in human iliac cancellous bone: independent correlations with osteoid width and osteoblastic alkaline phosphatase activity. J Bone Miner Res (1994) 1.41

Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis (1995) 1.27

Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain. J Cell Sci (1991) 1.26

Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J Cell Physiol (1992) 1.26

Purification and characterization of human 72-kDa gelatinase (type IV collagenase). Use of immunolocalisation to demonstrate the non-coordinate regulation of the 72-kDa and 95-kDa gelatinases by human fibroblasts. Biol Chem Hoppe Seyler (1991) 1.24

Differential expression of collagen types I, II, III, and X in human osteophytes. Lab Invest (1995) 1.14

Mouse osteoblasts synthesize collagenase in response to bone resorbing agents. Biochim Biophys Acta (1984) 1.13

Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate. J Bone Joint Surg Am (1989) 1.11

The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci (1994) 1.10

Effect of proteoglycans on in vitro hydroxyapatite formation. Calcif Tissue Int (1979) 1.06

Matrix metalloproteinases in blood vessel development in human fetal skin and in cutaneous tumors. J Invest Dermatol (1995) 1.05

Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. J Cell Sci (1992) 1.04

Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone. J Cell Sci (1993) 1.01

(Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment. J Cell Sci (1993) 0.92

Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts. J Bone Miner Res (1994) 0.91

Production of collagenase by human osteoblasts and osteoclasts in vivo. Bone (1996) 0.90

Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue. Endocrinology (1988) 0.90

Immunolocalization of collagenase and TIMP in healing human burn wounds. J Invest Dermatol (1994) 0.89

Parathyroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B. J Bone Miner Res (1996) 0.88

Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type 1 IGF receptor. Bone (1995) 0.88

Glycosaminoglycans and endochondral calcification. Clin Orthop Relat Res (1978) 0.84

Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone. Clin Exp Metastasis (1995) 0.81

Association of collagenase and tissue inhibitor of metalloproteinases (TIMP) with hypertrophic cell enlargement in the growth plate. Matrix (1989) 0.81

Vascular co-localization of proteolytic enzymes and proteinase inhibitors in advanced periodontitis. J Pathol (1996) 0.81

Matrix metalloproteinases and TIMP-1 localization at sites of osteogenesis in the craniofacial region of the rabbit embryo. Anat Rec (1995) 0.80

Bone-derived growth factors modulate collagenase and TIMP (tissue inhibitor of metalloproteinases) activity and type I collagen degradation by mouse calvarial osteoblasts. Bone Miner (1991) 0.80

Bioactivity of parathyroid hormone and parathyroid hormone-like peptide: agonist and antagonist activities of amino-terminal fragments as assessed by the cytochemical bioassay and in situ biochemistry. Endocrinology (1991) 0.79

The synthesis of collagenase, gelatinase-A (72 kDa) and -B (95 kDa), and TIMP-1 and -2 by human osteoblasts from normal and arthritic bone. Bone (1995) 0.78

Articles by these authors

Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J (1987) 4.56

Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature (1985) 3.97

Bone disease after jejuno-ileal bypass for obesity. Lancet (1978) 3.84

Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J (1986) 3.31

Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem (1996) 3.00

Milk consumption and bone mineral density in middle aged and elderly women. BMJ (1994) 2.85

Vitamin D deficiency: time for action. Evidence supports routine supplementation for elderly people and others at risk. BMJ (1998) 2.74

Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43

Stimulation by endocytosis of the secretion of collagenase and neutral proteinase from rabbit synovial fibroblasts. J Exp Med (1974) 2.36

Evidence that latent collagenases are enzyme-inhibitor complexes. Biochem J (1977) 2.32

Estrogen receptors alpha and beta are differentially expressed in developing human bone. J Clin Endocrinol Metab (2001) 2.23

Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components. Biochem J (1983) 2.17

Purification of rabbit bone inhibitor of collagenase. Biochem J (1981) 2.12

Comparison between the lengths of individual osteoid seams and resorption cavities in human iliac crest cancellous bone. Bone Miner (1993) 2.03

Osteoporosis in patients with inflammatory bowel disease. Gut (1987) 1.95

Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. Biochem J (1989) 1.89

Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. J Biol Chem (1985) 1.86

Treatment failure in osteoporosis. Osteoporos Int (2012) 1.82

Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr (1981) 1.79

Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum. J Cell Sci (1985) 1.73

The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J (1983) 1.72

Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens. Biochem J (1982) 1.66

The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes. Biochem J (1980) 1.64

Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem J (1981) 1.62

Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J Clin Invest (1992) 1.62

Neutral metallo-proteinases of rabbit bone. Separation in latent forms of distinct enzymes that when activated degrade collagen, gelatin and proteoglycans. Biochem J (1978) 1.60

Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. J Clin Pathol (1994) 1.60

The detection and characterisation of collagenase inhibitors from rabbit tissues in culture. Biochim Biophys Acta (1977) 1.57

Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen. Biochim Biophys Acta (1985) 1.56

Collagenase is a component of the specific granules of human neutrophil leucocytes. Biochem J (1977) 1.55

T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion. Rheumatology (Oxford) (2003) 1.52

An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. Biochem J (1981) 1.52

The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone (2003) 1.51

Characterization of a specific antiserum to rabbit stromelysin and demonstration of the synthesis of collagenase and stromelysin by stimulated rabbit articular chondrocytes. Coll Relat Res (1986) 1.50

The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann N Y Acad Sci (1992) 1.48

Treatment of osteomalacia with oral 1-alpha-hydroxyvitamin D3 in a patient with malabsorption. Br Med J (1977) 1.48

Bone density: BMC, BMD, or corrected BMD? Bone (1995) 1.47

Origin of plasma alpha2HS-glycoprotein and its accumulation in bone. Nature (1976) 1.41

Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem (1995) 1.41

Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J (1995) 1.41

Guidelines on the management of osteoporosis associated with chronic liver disease. Gut (2002) 1.40

Comparative performance in vitro and in vivo of Lunar DPX and Hologic QDR-1000 dual energy X-ray absorptiometers. Br J Radiol (1991) 1.40

Cytochalasin B increases collagenase production by cells in vitro. Nature (1975) 1.40

A new factor that may control collagen resorption. Lancet (1977) 1.38

The localization of androgen receptors in human bone. J Clin Endocrinol Metab (1997) 1.37

Pyrophosphate stimulation of calcium uptake into cultured embryonic bones. Fine structure of matrix vesicles and their role in calcification. Dev Biol (1973) 1.37

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int (2012) 1.36

Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. Biochem J (1992) 1.35

Inhibition by calcitonin of bone resorption induced in vitro by vitamin A. Proc R Soc Lond B Biol Sci (1968) 1.35

The origin of matrix metalloproteinases and their familial relationships. FEBS Lett (1991) 1.34

Identification and partial characterization of an inhibitor of collagenase from rabbit bone. Biochem J (1977) 1.34

Value of the history in diagnosis of histological osteomalacia among Asians presenting to the NHS. Lancet (1983) 1.33

Value of plasma calcium, phosphate, and alkaline phosphatase measurements in the diagnosis of histological osteomalacia. J Clin Pathol (1982) 1.29

Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J (1998) 1.29

Commitment to expression of the metalloendopeptidases, collagenase and stromelysin: relationship of inducing events to changes in cytoskeletal architecture. J Cell Biol (1986) 1.29

Rabbit bone collagenase inhibitor blocks the activity of other neutral metalloproteinases. Biochem Biophys Res Commun (1979) 1.29

Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim Biophys Acta (1991) 1.28

Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis (1995) 1.27

Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int (2001) 1.27

Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain. J Cell Sci (1991) 1.26

Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection. Gut (1977) 1.26

Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts. Ann Rheum Dis (2004) 1.25

The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. Biochem J (1991) 1.25

Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis. Lancet (1977) 1.25

Purification and characterization of human 72-kDa gelatinase (type IV collagenase). Use of immunolocalisation to demonstrate the non-coordinate regulation of the 72-kDa and 95-kDa gelatinases by human fibroblasts. Biol Chem Hoppe Seyler (1991) 1.24

Characterization of a specific antiserum for mammalian collagenase from several species: immunolocalization of collagenase in rabbit chondrocytes and uterus. J Cell Sci (1986) 1.22

Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int (2010) 1.19

Metalloproteinases and tissue damage. Br J Rheumatol (1991) 1.18

Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol (1992) 1.17

Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut (1993) 1.17

Role and regulation of metalloproteinases in connective tissue turnover. Biochem Soc Trans (1990) 1.17

Osteomalacia after small-intestinal resection. Lancet (1978) 1.16

Histomorphometric analysis of bone biopsies from the iliac crest of normal British subjects. Metab Bone Dis Relat Res (1982) 1.16

MT1-MMP on the cell surface causes focal degradation of gelatin films. FEBS Lett (1998) 1.15

Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J Clin Invest (1994) 1.15

Cathepsin D in cartilage: the immunohistochemical demonstration of extracellular enzyme in normal and pathological conditions. J Cell Sci (1974) 1.15

Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone. Bone (1998) 1.14

Pig interleukin 1 (catabolin) is a potent stimulator of bone resorption in vitro. Calcif Tissue Int (1985) 1.13

Mouse osteoblasts synthesize collagenase in response to bone resorbing agents. Biochim Biophys Acta (1984) 1.13

Metalloproteinase inhibitors from bovine cartilage and body fluids. Eur J Biochem (1984) 1.13

Immunochemical studies with a specific antiserum to rabbit fibroblast collagenase. Biochem J (1975) 1.11

Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate. J Bone Joint Surg Am (1989) 1.11

Secretion and localization of cathepsin D in synovial tissues removed from rheumatoid and traumatized joints. An immunohistochemical study. Arthritis Rheum (1977) 1.11

Role of collagenase in colonic anastomoses: a reappraisal. Br J Surg (1988) 1.11

Inhibition of type I collagen film degradation by tumour cells using a specific antibody to collagenase and the specific tissue inhibitor of metalloproteinases (TIMP). Cell Biol Int Rep (1985) 1.10

Gelatinase (type IV collagenase) immunolocalization in cells and tissues: use of an antiserum to rabbit bone gelatinase that identifies high and low Mr forms. J Cell Sci (1989) 1.10

The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci (1994) 1.10

Endochondral ossification in Achilles and patella tendinopathy. Rheumatology (Oxford) (2002) 1.10

Purification and properties of a specific collagenase from rabbit synovial fibroblasts. Biochem J (1975) 1.10